Home > PB Ratio > WINDLAS BIOTECH

WINDLAS BIOTECH
PB (Price/Book ) Ratio

The Current P/B Ratio of WINDLAS BIOTECH is 4.75.

Share Price ₹1,005.8Feb 04,2025
Market Cap ₹2,112.2 Cr
Book Value₹445.0 CrMar2024 - Consolidated Results
Price/Book 4.75xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of WINDLAS BIOTECH

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of WINDLAS BIOTECH is calculated as :

Current Market Cap [ ₹2,112.2 Cr] as on Feb 04,2025

(/) Book Value [ ₹445.0 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 4.75x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '4.75 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WINDLAS BIOTECH !

The chart below summarizes the trend in P/B Ratio of WINDLAS BIOTECH over the last five years.

Historical PB (Price/Book ) ratio chart of WINDLAS BIOTECH


PB Ratio Performance Analysis for WINDLAS BIOTECH

- WINDLAS BIOTECH 's latest p/b ratio is 4.75x.

- WINDLAS BIOTECH 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.95x.

- WINDLAS BIOTECH 's operated at median p/b ratio of 1.17x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/b ratio peaked in Mar2024 at 2.39x.

- WINDLAS BIOTECH 's p/b ratio hit its five-year low in Mar2021 of 0x.


How does WINDLAS BIOTECH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
WINDLAS BIOTECH 445.054.752,112.2
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.66423,974.0
CIPLA LTD26,619.904.40116,999.0
DR REDDYS LABORATORIES LTD28,123.503.62101,771.0
ZYDUS LIFESCIENCES LTD19,829.504.9497,951.9
DIVIS LABORATORIES LTD13,571.0011.92161,729.0
MANKIND PHARMA LTD9,339.8411.27105,258.0
TORRENT PHARMACEUTICALS LTD6,856.1515.33105,089.0
LUPIN LTD14,175.806.8096,354.0
AUROBINDO PHARMA LTD29,842.802.2868,023.5
ABBOTT INDIA LTD3,658.7315.1855,551.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WINDLAS BIOTECH 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.28x
Max industry PB 15.33x
Median industry PB 6.66x
Average industry PB 7.92x



You may also like the below Video Courses